Vimarsana
Biggest News Aggregation in the World

Cathy Dalene News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cathy Dalene. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cathy Dalene Today - Breaking & Trending Today

SMITH+NEPHEW SHARES NEW RESEARCH THAT ESTIMATES 3.5 BILLION HOURS OF NURSE TIME COULD BE RELEASED BY 2030 THROUGH SHARED WOUND CARE AND USE OF LONG-WEAR ADVANCED FOAM DRESSINGS - Vimarsana News

SMITH+NEPHEW SHARES NEW RESEARCH THAT ESTIMATES 3.5 BILLION HOURS OF NURSE TIME COULD BE RELEASED BY 2030 THROUGH SHARED WOUND CARE AND USE OF LONG-WEAR ADVANCED FOAM DRESSINGS

/PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces the publication of a new peer-reviewed article in Wounds...

Smith & Nephew plc: SMITH+NEPHEW SHARES NEW RESEARCH THAT ESTIMATES 3.5 BILLION HOURS OF NURSE TIME COULD BE RELEASED BY 2030 THROUGH SHARED WOUND CARE AND USE OF LONG-WEAR ADVANCED FOAM DRESSINGS - Vimarsana News

Smith & Nephew plc: SMITH+NEPHEW SHARES NEW RESEARCH THAT ESTIMATES 3.5 BILLION HOURS OF NURSE TIME COULD BE RELEASED BY 2030 THROUGH SHARED WOUND CARE AND USE OF LONG-WEAR ADVANCED FOAM DRESSINGS

LONDON, June 14, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces the publication of a new peer-reviewed article in Wounds International.

Smith+Nephew sponsored research shows COVID-19 has accelerated patient involvement in chronic wound care which can be supported by advanced foams such as ALLEVYN™ LIFE Dressing - Vimarsana News

Smith+Nephew sponsored research shows COVID-19 has accelerated patient involvement in chronic wound care which can be supported by advanced foams such as ALLEVYN™ LIFE Dressing

Share this article Share this article LONDON, April 30, 2021 /PRNewswire/ -- Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, announces the publication of new research showing that clinicians estimated that 45% of their patients with chronic wounds would benefit from greater involvement in their care, and half of these clinicians believed this would enable them to spend more time with other patients. 1 Smith+Nephew's ALLEVYN Life Dressing The results of the research, published in Wounds International, concluded that the COVID-19 pandemic had been instrumental in provid...

Smith+Nephew sponsored research shows COVID-19 has accelerated patient involvement in chronic wound care which can be supported by advanced foams such as ALLEVYN LIFE Dressing - Vimarsana News

Smith+Nephew sponsored research shows COVID-19 has accelerated patient involvement in chronic wound care which can be supported by advanced foams such as ALLEVYN LIFE Dressing

(1) LONDON, April 30, 2021 /PRNewswire/ -- Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, announces the publication of new research showing that clinicians estimated that 45% of their patients with chronic wounds would benefit from greater involvement in their care, and half of these clinicians believed this would enable them to spend more time with other patients. 1 The results of the research, published in Wounds International, concluded that the COVID-19 pandemic had been instrumental in providing a real-world opportunity for clinicians to better understand the be...

Smith+Nephew's PICO™ Single Use Negative Pressure Wound Therapy System again shown to significantly reduce surgical site complications - Vimarsana News

Smith+Nephew's PICO™ Single Use Negative Pressure Wound Therapy System again shown to significantly reduce surgical site complications

Smith+Nephew's PICO™ Single Use Negative Pressure Wound Therapy System again shown to significantly reduce surgical site complications News provided by Share this article Share this article LONDON, Jan. 27, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN,NYSE:SNN), the global medical technology business, is pleased to announce a new publication showing that its PICO Single Use Negative Pressure Wound Therapy System (sNPWT) significantly reduced the odds of surgical site infections (SSIs) by 63% *, the odds of seroma by 77% †, and the odds of dehiscence by 30% ‡. A significant benefit of these...